Taisho Pharmaceutical Co., Ltd.
3 live applications in ICANN's 2026 new gTLD round, one of 480 applicants, filed from JP.
Applications
Everything this applicant filed, live first. "Applicants" counts every live application for the same string, including this one — so 1 means sole applicant.
| String | Type | Applicants | Status | Set | Application ID |
|---|---|---|---|---|---|
| .lipovitan | New gTLD Brand | 1 | Active | – | TPCL2648T-T11392 |
| .taisho | New gTLD Brand | 1 | Active | – | TPCL2648T-T85554 |
| .upsa | New gTLD Brand | 1 | Active | – | TPCL2648T-T93473 |
About this page
Applicants are listed under the organisation name ICANN publishes, and matched to an existing registry operator only on an exact name match. Several groups file through a different legal entity from the one that signed their 2012 agreements, so an applicant who is in fact an incumbent may show no link here. Under-matching is deliberate: a fuzzy match would also join entities that merely look alike, and a reader could not tell which they were looking at.
Data currency. Domain counts on this page are from zone files dated and refresh daily. Registrar figures are from ICANN's monthly registry reports for June 2026, which ICANN publishes about three months in arrears; zone files contain no registrar information, so no fresher source exists. Full detail on methodology and live pipeline status.